ATTO Conversion Disclosure
Venbio Global Strategic Fund Iv, L.p. · SEC Form 4 · Filed Aug 10, 2026
Conversion
Calculated transaction value
$0
Venbio Global Strategic Fund Iv, L.p. 10% owner
ATTO
Transaction date
Aug 6, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 4 days later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series C Preferred Stock on Common Stock
- Quantity / price
- 6,179,219 shares @ $0
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000905148-26-003548
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$6.5M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO Current | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 6, 2026 | $6.5M |